Preoperative Radiotherapy and Local Excision in Rectal Cancer
The Randomised Study of Preoperative Radiotherapy and Local Excision for Radiosensitive Rectal Cancer
Sponsor: Maria Sklodowska-Curie National Research Institute of Oncology
A PHASE3 clinical study on Rectal Cancer, this trial is ongoing. The trial is conducted by Maria Sklodowska-Curie National Research Institute of Oncology and has accumulated 8 data snapshots since 2003. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Unknown PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Unknown PHASE3
Status: Unknown Status → Unknown
-
Jan 2022 — Jul 2024 [monthly]
Unknown Status PHASE3
-
Jan 2021 — Jan 2022 [monthly]
Unknown Status PHASE3
-
Jun 2018 — Jan 2021 [monthly]
Unknown Status PHASE3
▶ Show 3 earlier versions
-
May 2018 — Jun 2018 [monthly]
Unknown Status PHASE3
-
Feb 2017 — May 2018 [monthly]
Unknown Status PHASE3
-
Jan 2017 — Feb 2017 [monthly]
Unknown Status PHASE3
First recorded
Nov 2003
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Maria Sklodowska-Curie National Research Institute of Oncology
- Medical University of Lublin
- Polish Colorectal Cancer Study Group
- Poznan University of Medical Sciences
For direct contact, visit the study record on ClinicalTrials.gov .